Warning on bismacine.
D001729:Bismuth / Q000009:adverse effects / Q000506:poisoning*; D006801:Humans; D008193:Lyme Disease / Q000188:drug therapy*; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration
C518068:bismacine; D001729:Bismuth